Faculty

Laura Sangare

Affiliate Assistant Professor, Epidemiology


lsangare@uw.edu

Education

PhD Epidemiology, University of Washington, 2010
MPH Infectious Diseases, University of California (Berkeley), 2002
BS Physiology, University of California (Santa Barbara), 1998

Contact


lsangare@uw.edu

WA

Bio

Laura Sangaré is an infectious disease epidemiologist with a Ph.D. from the University of Washington and more than 15 years of experience in designing research studies and leading research agendas to support multidisciplinary public health projects focused on global health and infectious diseases.

Laura’s current role as an epidemiology consultant includes consulting on medicolegal cases, pharmaceutical product development, medical devices, technical writing, study methodology and data analysis.

Research Interests

Forensic epidemiology, infectious diseases, perinatal epidemiology, global health, malaria, and maternal and child health.

Recent Publications (PubMed)

Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix.
(2021 Nov)
Support Care Cancer 29(11): 6731-6740
Sangaré L, Divita A, Rehn M, McNamara M, Lowe KA

An evaluation of RAS testing among metastatic colorectal cancer patients in the USA.
(2021 May)
Future Oncol 17(13): 1653-1663
Sangaré L, Delli-Zotti K, Florea A, Rehn M, Benson AB, Lowe KA

Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials.
(2021 Jun)
Clin Colorectal Cancer 20(2): 170-176
Kilpatrick K, Shaw JL, Jaramillo R, Toler A, Eisen M, Sangaré L, Soff GA

A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer.
(2020 Oct)
Gastroenterology Res 13(5): 184-198
Levin-Sparenberg E, Bylsma LC, Lowe K, Sangare L, Fryzek JP, Alexander DD

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
(2020 Feb)
Cancer Med 9(3): 1044-1057
Bylsma LC, Gillezeau C, Garawin TA, Kelsh MA, Fryzek JP, Sangaré L, Lowe KA

Show complete publication list

In the News

No news articles at this time.